DE PLACIDO, SABINO
DE PLACIDO, SABINO
DIPARTIMENTO DI SANITA' PUBBLICA
ANTITUMOR ACTIVITY OF THE COMBINATION OF CETUXIMAB, AN ANTI-EGFR BLOCKING MONOCLONAL ANTIBODY AND ZD6474, AN INHIBITOR OF VEGFR AND EGFR TYROSINE KINASES.
2006 Morelli, Mp; Cascone, T; Troiani, T; Tuccillo, C; Bianco, Roberto; Normanno, N; Romano, M; Veneziani, BIANCA MARIA; Fontanini, G; Eckhardt, Sg; DE PLACIDO, Sabino; Tortora, Giampaolo; Ciardiello, F.
Zoledronic acid cooperates with a cyclooxygenase-2 inhibitor and gefitinib in inhibiting breast and prostate cancer.
2005 Melisi, Davide; Caputo, R; Damiano, Vincenzo; Bianco, Roberto; Veneziani, BIANCA MARIA; Bianco, Ar; DE PLACIDO, Sabino; Ciardiello, F; Tortora, Giampaolo
c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients.
1998 DE PLACIDO, Sabino; Carlomagno, C.; DE LAURENTIIS, Michelino; Bianco, A. R.
Measurement of neovascularization is an independent prognosticator of survival in node-negative breast cancer patients with long-term follow-up.
1999 DE PLACIDO, Sabino; Carlomagno, C.; Ciardiello, F.; DE LAURENTIIS, Michelino; Pepe, S.; Ruggiero, A.; Tortora, G.; Panico, L.; D'Antonio, A.; Pettinato, G.; Petrella, G.; Bianco, A. R.
Topotecan compared with no therapy after response to surgery and carboplatin/paclitaxel in patients with ovarian cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) randomized study.
2004 DE PLACIDO, Sabino; Scambia, G; DI VAGNO, G; Naglieri, E; Lombardi, Av; Biamonte, R; Marinaccio, M; Carteni, G; Manzione, L; Febbraro, A; DE MATTEIS, A; Gasparini, G; Valerio, Mr; Danese, S; Perrone, F; Lauria, Rossella; DE LAURENTIIS, Michelino; Greggi, S; Gallo, C; Pignata, S.
Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III study.
2005 DE PLACIDO, Sabino; Lopez, M; Carlomagno, Chiara; Paoletti, G; Palazzo, S; Manzione, L; Iannace, C; Ianniello, Gp; DE VITA, F; Ficorella, C; Farris, A; Pistillucci, G; Gemini, M; Cortesi, E; Adamo, V; Gebbia, N; Palmeri, S; Gallo, C; Perrone, F; Persico, G; Bianco, ANGELO RAFFAELE
Weekly docetaxel and capecitabine is not effective in the treatment of advanced gastric cancer: a phase II study.
2006 Orditura, M; Martinelli, E; Galizia, G; Carlomagno, Chiara; Aurilio, G; Vecchione, L; Lieto, E; DE PLACIDO, Sabino; Catalano, G; Ciardiello, F; DE VITA, F.
Pegylated liposomal doxorubicin in stage IVB mycosis fungoides
2005 DI LORENZO, G; DI TROLIO, R; Delfino, Mario; DE PLACIDO, Sabino
Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
2005 Arpino, Grazia; Weiss, H; Lee, Av; Schiff, R; DE PLACIDO, Sabino; Osborne, Ck; Elledge, R. M.
TLR9 agonist acts by different mechanisms synergizing with bevacizumab in sensitive and cetuximab-resistant colon cancer xenografts.
2007 Damiano, V; Caputo, R; Garofalo, S; Bianco, Roberto; Rosa, R; Merola, G; Gelardi, T; Racioppi, Luigi; Fontanini, G; DE PLACIDO, Sabino; Kandimalla, Er; Agrawal, S; Ciardiello, F; Tortora, Giampaolo
Docetaxel, vinorelbine, and zoledronic acid as first-line treatment in patients with hormone refractory prostate cancer: a phase II study.
2007 DI LORENZO, G; Autorino, R; Perdona, S; DE LAURENTIIS, Michelino; D'Armiento, FRANCESCO PAOLO; Cancello, G; Mirone, Vincenzo; Imbimbo, Ciro; Longo, Nicola; Altieri, Vincenzo; Tortora, Giampaolo; Figg, Wd; DE PLACIDO, Sabino
Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect.
2003 Tortora, G; Caputo, R; Damiano, V; Melisi, D; Bianco, Roberto; Fontanini, G; Veneziani, BIANCA MARIA; DE PLACIDO, Sabino; Bianco, ANGELO RAFFAELE; Ciardiello, F.
Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer.
2003 DE PLACIDO, Sabino; DE LAURENTIIS, Michelino; Carlomagno, Chiara; C., Gallo; F., Perrone; Pepe, Stefano; A., Ruggiero; Marinelli, Alfredo; Pagliarulo, Clorindo; Pettinato, Guido; G., Petrella; Bianco, ANGELO RAFFAELE
Prognostic significance of circulating immune complexes in a long term follow-up of breast cancer patients
1988 Iaffaioli, Rv; Bianchin, A.; Ruggiero, Giuseppina; Pirozzi, G.; Ungaro, A.; Totaro, G.; Gallo, C.; DE PLACIDO, Sabino; Pagliarulo, C.; Bianco, A. R.; Manzo, C.
NUCLEAR DNA CONTENT-DERIVED PARAMETERS CORRELATED WITH HETEROGENEOUS EXPRESSION PF P53 AND BCL-2 PROTEINS IN CLEAR CELL RENAL CARCINOMA
2000 Pepe, S; Ruggiero, A; D'Acquisto, M; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino
Survival Analysis by means of a novel Neural Network Model
2003 Eleuteri, A; Tagliaferri, R; DE PLACIDO, Sabino; DE LAURENTIIS, Michelino
Informed versus randomised consent to clinical trial
1995 Gallo, C; Perrone, F; DE PLACIDO, Sabino
EXPRESSION OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) CORRELATES WITH DISEASE RELAPSE AND PROGRESSION TO ANDROGEN-INDEPEDENCE IN HUMAN PROSTATE CANCER.
2002 DI LORENZO, G; Tortora, G; D'Armiento, FRANCESCO PAOLO; DE ROSA, G; Staibano, Stefania; Autorino, R; D'Armiento, Maria; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Catalano, G; Bianco, Ar; Ciardiello, F.
Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect.
2003 Tortora, G; Caputo, R; Damiano, V; Melisi, D; Bianco, Roberto; Fontanini, G; Veneziani, BIANCA MARIA; DE PLACIDO, Sabino; Bianco, Ar; Ciardiello, F.
Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer.
2003 DE PLACIDO, Sabino; DE LAURENTIIS, Michelino; Carlomagno, C; Gallo, C; Perrone, F; Pepe, S; Ruggiero, A; Marinelli, Alfredo; Pagliarulo, C; Panico, L; Pettinato, ; Petrella, G; Bianco, Ar
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| ANTITUMOR ACTIVITY OF THE COMBINATION OF CETUXIMAB, AN ANTI-EGFR BLOCKING MONOCLONAL ANTIBODY AND ZD6474, AN INHIBITOR OF VEGFR AND EGFR TYROSINE KINASES. | 1.1 Articolo in rivista | 2006 | Morelli, Mp; Cascone, T; Troiani, T; Tuccillo, C; Bianco, Roberto; Normanno, N; Romano, M; Veneziani, BIANCA MARIA; Fontanini, G; Eckhardt, Sg; DE PLACIDO, Sabino; Tortora, Giampaolo; Ciardiello, F. | |
| Zoledronic acid cooperates with a cyclooxygenase-2 inhibitor and gefitinib in inhibiting breast and prostate cancer. | 1.1 Articolo in rivista | 2005 | Melisi, Davide; Caputo, R; Damiano, Vincenzo; Bianco, Roberto; Veneziani, BIANCA MARIA; Bianco, Ar; DE PLACIDO, Sabino; Ciardiello, F; Tortora, Giampaolo | |
| c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients. | 1.1 Articolo in rivista | 1998 | DE PLACIDO, Sabino; Carlomagno, C.; DE LAURENTIIS, Michelino; Bianco, A. R. | |
| Measurement of neovascularization is an independent prognosticator of survival in node-negative breast cancer patients with long-term follow-up. | 1.1 Articolo in rivista | 1999 | DE PLACIDO, Sabino; Carlomagno, C.; Ciardiello, F.; DE LAURENTIIS, Michelino; Pepe, S.; Ruggiero, A.; Tortora, G.; Panico, L.; D'Antonio, A.; Pettinato, G.; Petrella, G.; Bianco, A. R. | |
| Topotecan compared with no therapy after response to surgery and carboplatin/paclitaxel in patients with ovarian cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) randomized study. | 1.1 Articolo in rivista | 2004 | DE PLACIDO, Sabino; Scambia, G; DI VAGNO, G; Naglieri, E; Lombardi, Av; Biamonte, R; Marinaccio, M; Carteni, G; Manzione, L; Febbraro, A; DE MATTEIS, A; Gasparini, G; Valerio, Mr; Danese, S; Perrone, F; Lauria, Rossella; DE LAURENTIIS, Michelino; Greggi, S; Gallo, C; Pignata, S. | |
| Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III study. | 1.1 Articolo in rivista | 2005 | DE PLACIDO, Sabino; Lopez, M; Carlomagno, Chiara; Paoletti, G; Palazzo, S; Manzione, L; Iannace, C; Ianniello, Gp; DE VITA, F; Ficorella, C; Farris, A; Pistillucci, G; Gemini, M; Cortesi, E; Adamo, V; Gebbia, N; Palmeri, S; Gallo, C; Perrone, F; Persico, G; Bianco, ANGELO RAFFAELE | |
| Weekly docetaxel and capecitabine is not effective in the treatment of advanced gastric cancer: a phase II study. | 1.1 Articolo in rivista | 2006 | Orditura, M; Martinelli, E; Galizia, G; Carlomagno, Chiara; Aurilio, G; Vecchione, L; Lieto, E; DE PLACIDO, Sabino; Catalano, G; Ciardiello, F; DE VITA, F. | |
| Pegylated liposomal doxorubicin in stage IVB mycosis fungoides | 1.1 Articolo in rivista | 2005 | DI LORENZO, G; DI TROLIO, R; Delfino, Mario; DE PLACIDO, Sabino | |
| Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance. | 1.1 Articolo in rivista | 2005 | Arpino, Grazia; Weiss, H; Lee, Av; Schiff, R; DE PLACIDO, Sabino; Osborne, Ck; Elledge, R. M. | |
| TLR9 agonist acts by different mechanisms synergizing with bevacizumab in sensitive and cetuximab-resistant colon cancer xenografts. | 1.1 Articolo in rivista | 2007 | Damiano, V; Caputo, R; Garofalo, S; Bianco, Roberto; Rosa, R; Merola, G; Gelardi, T; Racioppi, Luigi; Fontanini, G; DE PLACIDO, Sabino; Kandimalla, Er; Agrawal, S; Ciardiello, F; Tortora, Giampaolo | |
| Docetaxel, vinorelbine, and zoledronic acid as first-line treatment in patients with hormone refractory prostate cancer: a phase II study. | 1.1 Articolo in rivista | 2007 | DI LORENZO, G; Autorino, R; Perdona, S; DE LAURENTIIS, Michelino; D'Armiento, FRANCESCO PAOLO; Cancello, G; Mirone, Vincenzo; Imbimbo, Ciro; Longo, Nicola; Altieri, Vincenzo; Tortora, Giampaolo; Figg, Wd; DE PLACIDO, Sabino | |
| Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect. | 1.1 Articolo in rivista | 2003 | Tortora, G; Caputo, R; Damiano, V; Melisi, D; Bianco, Roberto; Fontanini, G; Veneziani, BIANCA MARIA; DE PLACIDO, Sabino; Bianco, ANGELO RAFFAELE; Ciardiello, F. | |
| Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer. | 1.1 Articolo in rivista | 2003 | DE PLACIDO, Sabino; DE LAURENTIIS, Michelino; Carlomagno, Chiara; C., Gallo; F., Perrone; Pepe, Stefano; A., Ruggiero; Marinelli, Alfredo; Pagliarulo, Clorindo; Pettinato, Guido; G., Petrella; Bianco, ANGELO RAFFAELE | |
| Prognostic significance of circulating immune complexes in a long term follow-up of breast cancer patients | 1.1 Articolo in rivista | 1988 | Iaffaioli, Rv; Bianchin, A.; Ruggiero, Giuseppina; Pirozzi, G.; Ungaro, A.; Totaro, G.; Gallo, C.; DE PLACIDO, Sabino; Pagliarulo, C.; Bianco, A. R.; Manzo, C. | |
| NUCLEAR DNA CONTENT-DERIVED PARAMETERS CORRELATED WITH HETEROGENEOUS EXPRESSION PF P53 AND BCL-2 PROTEINS IN CLEAR CELL RENAL CARCINOMA | 1.1 Articolo in rivista | 2000 | Pepe, S; Ruggiero, A; D'Acquisto, M; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino | |
| Survival Analysis by means of a novel Neural Network Model | 1.1 Articolo in rivista | 2003 | Eleuteri, A; Tagliaferri, R; DE PLACIDO, Sabino; DE LAURENTIIS, Michelino | |
| Informed versus randomised consent to clinical trial | 1.1 Articolo in rivista | 1995 | Gallo, C; Perrone, F; DE PLACIDO, Sabino | |
| EXPRESSION OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) CORRELATES WITH DISEASE RELAPSE AND PROGRESSION TO ANDROGEN-INDEPEDENCE IN HUMAN PROSTATE CANCER. | 1.1 Articolo in rivista | 2002 | DI LORENZO, G; Tortora, G; D'Armiento, FRANCESCO PAOLO; DE ROSA, G; Staibano, Stefania; Autorino, R; D'Armiento, Maria; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Catalano, G; Bianco, Ar; Ciardiello, F. | |
| Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect. | 1.1 Articolo in rivista | 2003 | Tortora, G; Caputo, R; Damiano, V; Melisi, D; Bianco, Roberto; Fontanini, G; Veneziani, BIANCA MARIA; DE PLACIDO, Sabino; Bianco, Ar; Ciardiello, F. | |
| Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer. | 1.1 Articolo in rivista | 2003 | DE PLACIDO, Sabino; DE LAURENTIIS, Michelino; Carlomagno, C; Gallo, C; Perrone, F; Pepe, S; Ruggiero, A; Marinelli, Alfredo; Pagliarulo, C; Panico, L; Pettinato, ; Petrella, G; Bianco, Ar |